Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. (SHE:300452)
China flag China · Delayed Price · Currency is CNY
15.77
+0.43 (2.80%)
Feb 4, 2026, 3:04 PM CST

SHE:300452 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20
Operating Revenue
924.08871.93827.17694.08607.27520.93
Other Revenue
10.6410.6412.0910.449.4310.26
934.72882.57839.26704.53616.71531.2
Revenue Growth (YoY)
10.85%5.16%19.12%14.24%16.10%14.46%
Cost of Revenue
646.9609.34573.93495.28438.93366.76
Gross Profit
287.82273.23265.33209.24177.78164.44
Selling, General & Admin
65.4263.546051.1352.0543.64
Research & Development
44.0740.9541.9534.4326.818.12
Other Operating Expenses
1.96-1.6922.725.855.34
Operating Expenses
111.4102.8103.9988.2384.766.93
Operating Income
176.42170.43161.34121.0193.0897.51
Interest Expense
-12.47-12.73-4.3-1.21-1.2-0.73
Interest & Investment Income
15.2420.1811.849.056.934.04
Currency Exchange Gain (Loss)
1.881.880.372.56-0.28-1
Other Non Operating Income (Expenses)
-1.04-0.42-0.41-0.38-0.39-0.17
EBT Excluding Unusual Items
180.04179.34168.84131.0298.1499.65
Impairment of Goodwill
-39.13-39.13---6.13-
Gain (Loss) on Sale of Investments
4.62-3.138.51-2.621.740.73
Gain (Loss) on Sale of Assets
-0.170.11-0.01-0.27-2.96-1.86
Asset Writedown
-0-0-1.02-0.01--
Other Unusual Items
7.515.179.58.295.898.65
Pretax Income
152.86142.36185.82136.496.68107.17
Income Tax Expense
23.2321.8321.25.4711.1413.65
Earnings From Continuing Operations
129.62120.52164.62130.9385.5493.52
Minority Interest in Earnings
-0.06-1.1-3.09-0.233.720.42
Net Income
129.56119.42161.54130.7189.2593.94
Net Income to Common
129.56119.42161.54130.7189.2593.94
Net Income Growth
-19.24%-26.07%23.58%46.45%-4.99%11.34%
Shares Outstanding (Basic)
232234234233235230
Shares Outstanding (Diluted)
238234241233235230
Shares Change (YoY)
-1.85%-2.88%3.29%-0.63%1.93%-1.27%
EPS (Basic)
0.560.510.690.560.380.41
EPS (Diluted)
0.540.510.670.560.380.41
EPS Growth
-17.71%-23.88%19.64%47.37%-6.79%12.78%
Free Cash Flow
157.9290.3977.3865.572.3564.19
Free Cash Flow Per Share
0.660.390.320.280.310.28
Dividend Per Share
0.3000.3000.2500.2500.2310.192
Dividend Growth
20.00%20.00%-8.32%20.02%30.02%
Gross Margin
30.79%30.96%31.61%29.70%28.83%30.96%
Operating Margin
18.87%19.31%19.22%17.18%15.09%18.36%
Profit Margin
13.86%13.53%19.25%18.55%14.47%17.69%
Free Cash Flow Margin
16.89%10.24%9.22%9.30%11.73%12.08%
EBITDA
236.04221.12200.12157.07127.77129.26
EBITDA Margin
25.25%25.05%23.84%22.30%20.72%24.33%
D&A For EBITDA
59.6250.6938.7836.0634.6831.76
EBIT
176.42170.43161.34121.0193.0897.51
EBIT Margin
18.87%19.31%19.22%17.18%15.09%18.36%
Effective Tax Rate
15.20%15.33%11.41%4.01%11.53%12.74%
Revenue as Reported
934.72882.57839.26704.53616.71531.2
Advertising Expenses
-0.970.860.640.440.55
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.